Literature DB >> 26677848

Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.

Jialu Li, Hongwei Liang, Ming Bai, Tao Ning, Cheng Wang, Qian Fan, Yanbo Wang, Zheng Fu, Nan Wang, Rui Liu, Ke Zen, Chen-Yu Zhang, Xi Chen, Yi Ba.   

Abstract

Entities:  

Year:  2015        PMID： 26677848      PMCID： PMC4683101          DOI： 10.1371/journal.pone.0145589

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The affiliation for the fourteenth author is incorrect. Yi Ba is not affiliated with #2 but with #1Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tiyuanbei, Tianjin, 300060, China.
  1 in total

1.  miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.

Authors:  Jialu Li; Hongwei Liang; Ming Bai; Tao Ning; Cheng Wang; Qian Fan; Yanbo Wang; Zheng Fu; Nan Wang; Rui Liu; Ke Zen; Chen-Yu Zhang; Xi Chen; Yi Ba
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240
  1 in total
  1 in total

1.  A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer.

Authors:  Ding Ye; Yunqing Hu; Fangyuan Jing; Yingjun Li; Simeng Gu; Xiyi Jiang; Yingying Mao; Qilong Li; Mingjuan Jin; Kun Chen
Journal:  J Hum Genet       Date:  2017-10-05       Impact factor: 3.172
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.